Patents by Inventor Timo Niedermeyer

Timo Niedermeyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified microcystins and nodularins
    Patent number: 11512114
    Abstract: A compound includes cytotoxic agents such as microcystin and nodularin. More specifically, a modified microcystin and/or nodularin compound contains one or more modified substrates, wherein one or more modified substrates include an anchor group directly accessible or transformable for use in conjugation chemistry (incl. click chemistry), for the attachment of a targeting moiety. This compound is useful for cancer treatment.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: November 29, 2022
    Assignee: Cyano Biotech GmbH
    Inventors: Heike Enke, Wolfram Lorenzen, Stefan Jahns, Dan Enke, Timo Niedermeyer, Julia Moschny
  • Method for modifying microcystins and nodularins
    Patent number: 11124818
    Abstract: A method is used for producing a modified non-ribosomal peptide, e.g. a modified microcystin and/or modified nodularin (together CA), including the steps of: a) growing a modified non-ribosomal peptide producing cyanobacteria strain in a culture media, h) adding one or more modified substrates, preferably modified amino acids to said culture, and c) inoculating the non-ribosomal peptide, producing strain the presence of said modified substrates. The thus modified non-ribosomal peptide may be used for the therapy of various diseases.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: September 21, 2021
    Assignee: Cyano Biotech GmbH
    Inventors: Heike Enke, Wolfram Lorenzen, Stefan Jahns, Dan Enke, Timo Niedermeyer, Julia Moschny
  • METHOD FOR MODIFYING MICROCYSTINS AND NODULARINS
    Publication number: 20200377922
    Abstract: A method is used for producing a modified non-ribosomal peptide, e.g. a modified microcystin and/or modified nodularin (together CA), including the steps of a) growing a modified non-ribosomal peptide producing cyanobacteria strain in a culture media, b) adding one or more modified substrates, preferably modified amino acids to said culture, and c) inoculating the non-ribosomal peptide, producing strain the presence of said modified substrates. The thus modified non-ribosomal peptide may be used for the therapy of various diseases.
    Type: Application
    Filed: May 9, 2018
    Publication date: December 3, 2020
    Applicant: Cyano Biotech GmbH
    Inventors: Heike Enke, Wolfram Lorenzen, Stefan Jahns, Dan Enke, Timo Niedermeyer, Julia Moschny
  • MODIFIED MICROCYSTINS AND NODULARINS
    Publication number: 20200087348
    Abstract: A compound includes cytotoxic agents such as microcystin and nodularin. More specifically, a modified microcystin and/or nodularin compound contains one or more modified substrates, wherein one or more modified substrates include an anchor group directly accessible or transformable for use in conjugation chemistry (incl. click chemistry), for the attachment of a targeting moiety. This compound is useful for cancer treatment.
    Type: Application
    Filed: May 9, 2018
    Publication date: March 19, 2020
    Applicant: Cyano Biotech GmbH
    Inventors: Heike Enke, Wolfram Lorenzen, Stefan Jahns, Dan Enke, Timo Niedermeyer, Julia Moschny